Lost in the market's sharp rotation out of tech stocks is a really bullish call on major banks
Neuralink rival Synchron's brain implant now lets people control Apple's Vision Pro with their minds
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
We're encouraged by Abbott stock trading but discouraged by moves in Honeywell
Here are JPMorgan's top drug stock picks into earnings
Jim Cramer's advice on Abbott Labs stock after a nearly $500 million baby formula verdict
